Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotropin in Short Children Born Small for Gestational Age
NCT00174421Phase 3Completed
- Sponsor
- Pfizer
- Start
- Apr 2001
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
01
Overview
Phase 3, open-label trial of genotropin miniquick in short stature (2 arms), sponsored by Pfizer. Primary endpoint: Final height, compared to the expected familial target height. Started Apr 2001; status: completed.
02
Drugs
genotropin miniquick
03
Conditions
short stature
Beyond the preview
Go deeper on NCT00174421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174421.